Ligand validation:6XXJ

NAD: NICOTINAMIDE-ADENINE-DINUCLEOTIDE

	Best-fitted instance in this entry
	Other instances in this entry

	Best-fitted instance in this entry
	Best-fitted PDB instances with same target (top 5)

	Best-fitted instance in this entry
	Best-fitted PDB instances with different target (top 5)

Identifier	Ranking for goodness of fit	Ranking for geometry	Real space R factor	Real space correlation coefficient	RMSZ-bond-length	RMSZ-bond-angle	Outliers of bond length	Outliers of bond angle	Atomic clashes	Stereochemical errors	Model completeness	Average occupancy
6XXJ_NAD_A_402	81%	35%	0.116	0.968	1.14	1.43	4	6	1	0	100%	0.94
6XXJ_NAD_B_404	61%	32%	0.12	0.908	1.2	1.51	5	11	6	0	100%	0.9
8A0F_NAD_B_403	90%	56%	0.083	0.965	0.66	1.01	-	2	1	0	100%	1
6P4V_NAD_A_501	85%	56%	0.11	0.976	0.73	0.98	1	3	1	0	100%	1
8A0G_NAD_A_403	85%	53%	0.112	0.978	0.81	1	-	4	0	0	100%	1
1DHS_NAD_A_700	84%	27%	0.108	0.971	1.47	1.47	7	7	2	0	100%	1
6XXI_NAD_B_1510	77%	50%	0.133	0.974	1.03	0.9	2	2	0	0	100%	0.97
3CMC_NAD_R_408	100%	20%	0.016	0.998	1.63	1.74	4	9	0	0	100%	1
3EC7_NAD_A_400	100%	18%	0.025	0.995	1.8	1.74	5	8	1	0	100%	1
4URF_NAD_A_1249	100%	44%	0.034	0.995	0.96	1.2	2	4	0	0	100%	1
2C5A_NAD_B_1374	100%	23%	0.039	0.992	1.34	1.84	6	7	1	0	100%	1
1HET_NAD_A_402	100%	10%	0.043	0.994	2.25	2.1	9	8	0	0	100%	0.9068

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM157729.